GlassScriptPhysician profile
Sylvia Bucharowski
NPI 1346766094
$6,096.47
in general payments reported to CMS, 2019-2025
34 companies · $1,759 in 2025
The $1,759 reported for 2025 was more than what 92% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $466 · 2022: $793 · 2023: $1,402 · 2024: $1,676 · 2025: $1,759.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,757 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,757.38 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,210.20 | 2021-2025 | Watchman Flx, Watchman Access System, Watchman |
| Philips North America LLC | $801.62 | 2023-2025 | Technical Education Mri, (6536) Phoenix, (9281) Turbo Elite |
| Amgen INC. | $454.30 | 2021-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $425.47 | 2023-2025 | |
| Esperion Therapeutics, INC. | $372.87 | 2021-2025 | Nexletol |
| Novo Nordisk INC | $309.11 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Pfizer INC. | $298.56 | 2022-2025 | |
| Medtronic, INC. | $289.70 | 2023-2025 | Hawkone, Azure Xt Dr Mri Surescan, Venaseal |
| Abiomed | $192.14 | 2025 | |
| Merck Sharp & Dohme LLC | $179.66 | 2022-2024 | Verquvo, Steglatro, Belsomra |
| E.R. Squibb & Sons, L.L.C. | $166.73 | 2022-2025 | Eliquis, Camzyos |
| Shockwave Medical, INC | $157.65 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $151.73 | 2021-2024 | Farxiga |
| Cardiovascular Systems INC. | $139.17 | 2022 | |
| Janssen Pharmaceuticals, INC | $137.85 | 2024 | Xarelto |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $125.53 | 2022-2023 | Barostim Neo System |
| Kowa Pharmaceuticals America, INC. | $120.07 | 2021-2023 | Livalo |
| Amarin Pharma, INC. | $101.74 | 2021-2023 | |
| Bridgebio Pharma, INC. | $72.29 | 2025 | Attruby |
| Bayer Healthcare Pharmaceuticals INC. | $52.18 | 2025 | |
| Abbott Laboratories | $50.73 | 2024-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Alnylam Pharmaceuticals INC. | $48.29 | 2024-2025 | Amvuttra, Onpattro |
| Sanofi-Aventis U.S. LLC | $37.97 | 2022-2023 | |
| Exact Sciences Corporation | $24.46 | 2025 | Cologuard Collection Kit |
| Cardiva Medical, INC. | $24.00 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Cordis US Corp. | $22.45 | 2023 | Rain Sheath Transradial |
| Lexicon Pharmaceuticals, INC. | $21.94 | 2024 | |
| Scpharmaceuticals INC. | $18.36 | 2025 | |
| Cleerly, INC. | $16.38 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Lilly USA, LLC | $16.31 | 2025 | Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.63 | 2024 | Jardiance |
| Regeneron Healthcare Solutions, INC. | $14.92 | 2021 | |
| Ani Pharmaceuticals, INC. | $14.41 | 2024 | Purified Cortrophin Gel |
| Arbor Pharmaceuticals, INC. | $12.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sylvia Bucharowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.